Endothelin-1-mediated Brainstem Glial Activation Produces Asthmatic Airway Vagal Hypertonia Via Enhanced ATP-P2X4 Receptor Signaling in Sprague–Dawley Rats
The occurrence of major asthma symptoms is largely attributed to airway vagal hypertonia, of which the central mechanisms remain unclear. This study tests the hypotheses that endothelin-1-mediated brainstem glial activation produces asthmatic airway vagal hypertonia via enhanced action of adenosine 5’-triphosphate on neuronal purinergic P2X4 receptors. A rat model of asthma was prepared using ovalbumin. Airway vagal tone was evaluated by the recurrent laryngeal discharge and plethysmographic measurement of pulmonary function. The changes in the brainstem were examined using ELISA, Western blot, luciferin-luciferase, quantitative reverse transcription-polymerase chain reaction, enzyme activity assay and immunofluorescent staining, respectively. The results showed that in the medulla of rats, endothelin receptor type B and P2X4 receptors were primarily expressed in astrocytes and neurons, respectively, and both of which, along with endothelin-1 content, were significantly increased after ovalbumin sensitization. Ovalbumin sensitization significantly increased recurrent laryngeal discharge, which was blocked by acute intracisternal injection of P2X4 receptor antagonist 5-BDBD, knockdown of brainstem P2X4 receptors, and chronic intraperitoneal injection of endothelin receptor type B antagonist BQ788, respectively. Ovalbumin sensitization activated microglia and astrocytes and significantly decreased ecto-5’-nucleotidase activity in the medulla, and all of which, together with the increase of medullary P2X4 receptor expression and decrease of pulmonary function, were reversed by chronic BQ788 treatment. These results demonstrated that in rats, allergic airway challenge activates both microglia and astrocytes in the medulla via enhanced endothelin-1/endothelin receptor type B signaling, which subsequently causes airway vagal hypertonia via augmented adenosine 5’-triphosphate/P2X4 receptor signaling in central neurons of airway vagal reflex. Graphical Abstract.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Journal of neuroImmune pharmacology - 19(2024), 1 vom: 13. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lin, Yun [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Airway vagal nerves |
Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
---|
doi: |
10.1007/s11481-024-10116-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR055518613 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR055518613 | ||
003 | DE-627 | ||
005 | 20240414064633.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240414s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11481-024-10116-y |2 doi | |
035 | |a (DE-627)SPR055518613 | ||
035 | |a (SPR)s11481-024-10116-y-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.38 |2 bkl | ||
084 | |a 44.90 |2 bkl | ||
100 | 1 | |a Lin, Yun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Endothelin-1-mediated Brainstem Glial Activation Produces Asthmatic Airway Vagal Hypertonia Via Enhanced ATP-P2X4 Receptor Signaling in Sprague–Dawley Rats |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
520 | |a The occurrence of major asthma symptoms is largely attributed to airway vagal hypertonia, of which the central mechanisms remain unclear. This study tests the hypotheses that endothelin-1-mediated brainstem glial activation produces asthmatic airway vagal hypertonia via enhanced action of adenosine 5’-triphosphate on neuronal purinergic P2X4 receptors. A rat model of asthma was prepared using ovalbumin. Airway vagal tone was evaluated by the recurrent laryngeal discharge and plethysmographic measurement of pulmonary function. The changes in the brainstem were examined using ELISA, Western blot, luciferin-luciferase, quantitative reverse transcription-polymerase chain reaction, enzyme activity assay and immunofluorescent staining, respectively. The results showed that in the medulla of rats, endothelin receptor type B and P2X4 receptors were primarily expressed in astrocytes and neurons, respectively, and both of which, along with endothelin-1 content, were significantly increased after ovalbumin sensitization. Ovalbumin sensitization significantly increased recurrent laryngeal discharge, which was blocked by acute intracisternal injection of P2X4 receptor antagonist 5-BDBD, knockdown of brainstem P2X4 receptors, and chronic intraperitoneal injection of endothelin receptor type B antagonist BQ788, respectively. Ovalbumin sensitization activated microglia and astrocytes and significantly decreased ecto-5’-nucleotidase activity in the medulla, and all of which, together with the increase of medullary P2X4 receptor expression and decrease of pulmonary function, were reversed by chronic BQ788 treatment. These results demonstrated that in rats, allergic airway challenge activates both microglia and astrocytes in the medulla via enhanced endothelin-1/endothelin receptor type B signaling, which subsequently causes airway vagal hypertonia via augmented adenosine 5’-triphosphate/P2X4 receptor signaling in central neurons of airway vagal reflex. Graphical Abstract | ||
650 | 4 | |a Airway vagal nerves |7 (dpeaa)DE-He213 | |
650 | 4 | |a Asthma |7 (dpeaa)DE-He213 | |
650 | 4 | |a Ecto-5’-nucleotidase |7 (dpeaa)DE-He213 | |
650 | 4 | |a Endothelin-1 |7 (dpeaa)DE-He213 | |
650 | 4 | |a Glial cell |7 (dpeaa)DE-He213 | |
650 | 4 | |a Receptor |7 (dpeaa)DE-He213 | |
700 | 1 | |a Liu, Tian |e verfasserin |4 aut | |
700 | 1 | |a Chen, Hong |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Ming |e verfasserin |4 aut | |
700 | 1 | |a Hu, Shunwei |e verfasserin |4 aut | |
700 | 1 | |a Yu, Xiaoning |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yonghua |e verfasserin |4 aut | |
700 | 1 | |a Xia, Chunmei |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jijiang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neuroImmune pharmacology |d Springer US, 2006 |g 19(2024), 1 vom: 13. Apr. |w (DE-627)SPR020022093 |w (DE-600)2227405-4 |x 1557-1904 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2024 |g number:1 |g day:13 |g month:04 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11481-024-10116-y |m X:VERLAG |x 0 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_SPRINGER | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.38 |q VZ |
936 | b | k | |a 44.90 |q VZ |
951 | |a AR | ||
952 | |d 19 |j 2024 |e 1 |b 13 |c 04 |